REG - Reckitt Benckiser Gp - SHARE CONSOLIDATION EFFECTIVE & TOTAL VOTING RIGHT

Reckitt BenckiserAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260202:nRSB1944Ra&default-theme=true

RNS Number : 1944R  Reckitt Benckiser Group PLC  02 February 2026

RECKITT BENCKISER GROUP PLC

SHARE CONSOLIDATION EFFECTIVE AND TOTAL VOTING RIGHTS

Further to the announcement on 27 January 2026 that shareholder approval was
granted at the General Meeting for a Special Dividend and associated Share
Consolidation, Reckitt Benckiser Group plc (the "Company") is pleased to
announce that the Company's Share Consolidation becomes effective today.

Admission of the Company's new ordinary shares to the ESCC category of the
Official List of the Financial Conduct Authority and to trading on the London
Stock Exchange's Main Market for listed securities, is due to take place at
8.00 a.m. today.

The ISIN for the new ordinary shares is GB00BSZBP530.

As a result of the Share Consolidation and in accordance with the requirements
of the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, the Company
hereby notifies the market that the Company's issued share capital as at 8.00
a.m. on 2 February 2026 will consist of 674,005,752 ordinary shares of
10⁵⁄₁₂ pence each. The Company will hold 29,252,346 ordinary shares in
treasury. Therefore, the total number of voting rights in the Company as at 2
February 2026 will be 644,753,406. 644,753,406 may be used by shareholders and
others with notification obligations as their denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.

Capitalised terms used but not otherwise defined in this announcement have the
same meaning given to them in the Circular dated 7 January 2026.

For further Information:

Catheryn O'Rourke

Company Secretary

Tel. 01753 217 800

103-105 Bath Road, Slough SL1 3UH

Registered in England and Wales, No. 6270876

About Reckitt:

We make the products people trust to care for the ones they love. We are home
to some of the world's best-loved consumer health and hygiene brands,
including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen,
Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By
creating innovative, science-backed solutions, we support people every day to
live healthier lives.

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner,
healthier world. This commitment goes beyond the products we make. Through our
actions, we expand access to healthcare, education and economic opportunities.
We support the planet by reducing waste, conserving resources and driving
sustainable innovation.

We believe good health starts at home. With every action we take, we strive to
make our consumers' lives easier, cleaner and healthier, to strengthen
communities and to create a more sustainable future.

*Reckitt is the trading name of the Reckitt group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRBBMBTMTAJBFF



            Copyright 2019 Regulatory News Service, all rights reserved